{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:41:45Z","timestamp":1793986905893,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the grant from the Science and Technology Program of Ningbo, China","award":["Grant no.2020Y55"],"award-info":[{"award-number":["Grant no.2020Y55"]}]},{"name":"The grand from Xuzhou medical university affiliated Xuzhou Municipal hospital development Grands","award":["Grands no. XYFM2020028."],"award-info":[{"award-number":["Grands no. XYFM2020028."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To determine whether photobiomodulation (PBM) therapy can retard ocular axial length (AL) in children with myopia. A randomized controlled clinical trial was conducted on two consecutive cohorts of 50 eligible children aged 8\u201312\u00a0years with \u2264\u2009\u2212\u20090.75 Diopter (D) of spherical equivalent refraction (SER). Participants were randomly assigned to the intervention group (n\u2009=\u200925) and treated with PBM therapy or the control group (n\u2009=\u200925) and treated with single vision spectacles only. At the 12-month follow-up, the changes in AL and cycloplegic SER from baseline were both compared between the two groups. In addition, the subfoveal choroidal thickness (SFChT), anterior chamber depth (ACD), and central corneal refractive power (CCP) were analysed at the 3-, 6-, 9-, and 12-month follow-ups, respectively. Among the 50 children, 78% were included at the final follow-up, with a mean age of 9.7\u2009\u00b1\u20091.5\u00a0years and a mean SER of \u2212\u20092.56\u2009\u00b1\u20091.70. The mean difference in AL growth between the two groups at 12\u00a0months was 0.50\u00a0mm (PBM vs. Control, \u2212\u20090.02\u00a0mm\u2009\u00b1\u20090.11 vs. 0.48\u00a0mm\u2009\u00b1\u20090.16,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001), and the mean difference in cycloplegic SER at 12\u00a0months was +\u20091.25 D (PBM vs. Control, +\u20090.28 D\u2009\u00b1\u20090.26 vs. \u2212\u20090.97 D\u2009\u00b1\u20090.25,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). There were no significant differences in any of the other parameters (including SFChT, ACD, and CCP) between the two groups at any time point. PBM therapy is an effective intervention for slightly decreasing the AL to control myopia in children.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Trial registration<\/jats:italic>\n                    : Chinese Clinical Trial Registration Number: ChiCTR2100043619. Registered on 23\/02\/2021; prospectively registered.\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=121302\">http:\/\/www.chictr.org.cn\/showproj.aspx?proj=121302<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-30500-7","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:04:30Z","timestamp":1677477870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2895-6819","authenticated-orcid":false,"given":"Lei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-5629","authenticated-orcid":false,"given":"Liyang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5195-7564","authenticated-orcid":false,"given":"Kaikai","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"30500_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ophtha.2017.12.011","volume":"125","author":"PC Wu","year":"2018","unstructured":"Wu, P. C. et al. Myopia prevention and outdoor light intensity in a school-based cluster randomized trial. Ophthalmology 125, 1239\u20131250 (2018).","journal-title":"Ophthalmology"},{"key":"30500_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1167\/iovs.11-8652","volume":"53","author":"EL Smith 3rd","year":"2012","unstructured":"Smith, E. L. 3rd., Huang, L. F. & Huang, J. Protective effects of high ambient lighting on the development of form-deprivation myopia in rhesus monkeys. Investig. Ophthalmol. Vis. Sci. 53, 421\u2013428 (2012).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"30500_CR3","doi-asserted-by":"publisher","first-page":"8915867","DOI":"10.1155\/8915867","volume":"1","author":"F Xiong","year":"2021","unstructured":"Xiong, F. et al. Orthokeratology and low-intensity laser therapy for slowing the progression of myopia in children. Biomed. Res. Int. 1, 8915867. https:\/\/doi.org\/10.1155\/8915867 (2021).","journal-title":"Biomed. Res. Int."},{"key":"30500_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/opo.12939","volume":"42","author":"L Zhou","year":"2022","unstructured":"Zhou, L., Xing, C., Wei, Q., Hua, C. & Tong, L. Low-intensity, long-wavelength red light slows the progression of myopia in children: An Eastern China-based Cohort. Ophthalmic Physiol. Opt. 42, 335\u2013344 (2022).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"30500_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Effect of repeated low-level red-light therapy in myopia control in children: A multicenter randomized controlled trial. Ophthalmology 129, 509\u2013519 (2022).","journal-title":"Ophthalmology"},{"key":"30500_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong, J., Zhu, Z., Xu, H. & He, M. Myopia control effect of repeated low-level red-light therapy in Chinese children: A randomized, double-blind, controlled clinical trial. Ophthalmology 130, 198\u2013204 (2023).","journal-title":"Ophthalmology"},{"key":"30500_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ceo.14149","volume":"50","author":"R Xiong","year":"2022","unstructured":"Xiong, R. et al. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study. Clin. Exp. Ophthalmol. 50, 1013\u20131024 (2022).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"30500_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","volume":"261","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: A randomized controlled trial. Graefes Arch. Clin. Exp. Ophthalmol. 261, 575\u2013584 (2023).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"30500_CR9","unstructured":"Zhao, Y., et al. The ocular axis length was shortened by 1.03mm with decreased myopic refraction of \u22123.00D. Don't believe myopia cannot be treated. WeChat. https:\/\/mp.weixin.qq.com\/s\/1_c_omBDYnTGnXphEdHhUw (2022). https:\/\/mp.weixin.qq.com\/s\/N6FIBwVizHntd4L62Ow81g (2022)."},{"key":"30500_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1167\/iovs.03-0294","volume":"45","author":"RA Stone","year":"2004","unstructured":"Stone, R. A. et al. Diurnal axial length fluctuations in human eyes. Investig. Ophthalmol. Vis. Sci. 45, 63\u201370 (2004).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"30500_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaapos.2015.04.006","volume":"19","author":"S Yi","year":"2015","unstructured":"Yi, S. et al. Therapeutic effect of atropine 1% in children with low myopia. J. AAPOS 19, 426\u2013429 (2015).","journal-title":"J. AAPOS"},{"key":"30500_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia, A. et al. Atropine for the treatment of childhood myopia: Safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology 119, 347\u2013354 (2012).","journal-title":"Ophthalmology"},{"key":"30500_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00417-018-3906-z","volume":"256","author":"A Ruiz-Pomeda","year":"2018","unstructured":"Ruiz-Pomeda, A. et al. MiSight assessment study Spain (MASS) a 2-year randomized clinical trial. Graefes Arch. Clin. Exp. Ophthalmol. 256, 1011\u20131021 (2018).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"30500_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","volume":"96","author":"P Chamberlain","year":"2019","unstructured":"Chamberlain, P. et al. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom. Vis. Sci. 96, 556\u2013567 (2019).","journal-title":"Optom. Vis. Sci."},{"key":"30500_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam, J. C. et al. Low-concentration atropine for myopia progression (LAMP) study: A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology 126, 113\u2013124 (2019).","journal-title":"Ophthalmology"},{"key":"30500_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam, J. C. et al. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: Phase 2 report. Ophthalmology 127, 910\u2013919 (2020).","journal-title":"Ophthalmology"},{"key":"30500_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CS Lam","year":"2020","unstructured":"Lam, C. S. et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: A 2-year randomized clinical trial. Br. J. Ophthalmol. 104, 363\u2013368 (2020).","journal-title":"Br. J. Ophthalmol."},{"key":"30500_CR18","first-page":"1110","volume":"106","author":"CS Lam","year":"2022","unstructured":"Lam, C. S. et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: Results of a 3-year follow-up study. Br. J. Ophthalmol. 106, 1110\u20131114 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"30500_CR19","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho, P. et al. Retardation of myopia in orthokeratology (ROMIO) study: A 2-year randomized clinical trial. Investig. Ophthalmol. Vis. Sci. 53, 7077\u20137085 (2012).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"30500_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s40123-022-00644-2","volume":"1","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Clinically significant axial shortening in myopic children after repeated low-lever red light therapy: A retrospective multicenter analysis. Ophthalmol. Ther. 1, 2. https:\/\/doi.org\/10.1007\/s40123-022-00644-2 (2023).","journal-title":"Ophthalmol. Ther."},{"key":"30500_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/tvst.11.10.33","volume":"11","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: A randomized controlled trial. Transl. Vis. Sci. Technol. 11, 33 (2022).","journal-title":"Transl. Vis. Sci. Technol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30500-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30500-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30500-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:15:55Z","timestamp":1677478555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30500-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30500"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30500-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2221339\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3321"}}